CTRE vs JAZZ · P/E 33, rev $296.3M vs P/E 1988, rev $4.07B
CareTrust REIT Inc. (CTRE) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
CareTrust REIT Inc. (CTRE) is a reit - healthcare facilities company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported CTRE revenue for 2024-12-31 was $296.3M. Net income was $124.4M. Revenue was up 36.1% from 2023-12-31 to 2024-12-31. CTRE currently screens at market cap $5.86B and trailing P/E 32.9.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
CTRE currently screens at market cap $5.86B and trailing P/E 32.9. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the CTRE and JAZZ stock pages for the full models.
Not investment advice.